CADL
Price
$6.47
Change
+$0.28 (+4.52%)
Updated
Oct 13 closing price
Capitalization
355.17M
23 days until earnings call
RNAC
Price
$9.46
Change
-$0.03 (-0.32%)
Updated
Oct 14, 02:16 PM (EDT)
Capitalization
246.89M
Interact to see
Advertisement

CADL vs RNAC

Header iconCADL vs RNAC Comparison
Open Charts CADL vs RNACBanner chart's image
Candel Therapeutics
Price$6.47
Change+$0.28 (+4.52%)
Volume$685.08K
Capitalization355.17M
Cartesian Therapeutics
Price$9.46
Change-$0.03 (-0.32%)
Volume$750
Capitalization246.89M
CADL vs RNAC Comparison Chart in %
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. RNAC commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongBuy and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (CADL: $6.47 vs. RNAC: $9.49)
Brand notoriety: CADL and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 92% vs. RNAC: 69%
Market capitalization -- CADL: $355.17M vs. RNAC: $246.89M
CADL [@Biotechnology] is valued at $355.17M. RNAC’s [@Biotechnology] market capitalization is $246.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, both CADL and RNAC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 6 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 6 bullish, 4 bearish.
  • RNAC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than RNAC.

Price Growth

CADL (@Biotechnology) experienced а +18.28% price change this week, while RNAC (@Biotechnology) price change was -5.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +80.86%.

Reported Earning Dates

CADL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($355M) has a higher market cap than RNAC($247M). CADL YTD gains are higher at: -25.461 vs. RNAC (-46.985). CADL has higher annual earnings (EBITDA): -19.74M vs. RNAC (-118.73M). RNAC has more cash in the bank: 160M vs. CADL (101M). CADL has less debt than RNAC: CADL (8.34M) vs RNAC (13.3M). RNAC has higher revenues than CADL: RNAC (1.03M) vs CADL (0).
CADLRNACCADL / RNAC
Capitalization355M247M144%
EBITDA-19.74M-118.73M17%
Gain YTD-25.461-46.98554%
P/E RatioN/A1.98-
Revenue01.03M-
Total Cash101M160M63%
Total Debt8.34M13.3M63%
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
40
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLRNAC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMRNY28.120.54
+1.96%
OMRON Corp.
DPXCF0.04N/A
N/A
DelphX Capital Markets Inc.
PFGTF0.10N/A
N/A
Pacific Edge Limited
FRFHF1746.51-2.07
-0.12%
Fairfax Financial Holdings Ltd.
ALPKF0.58-0.01
-1.01%
Alpek SAB DE CV

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.52%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
43%
Loosely correlated
+1.11%
MDGL - CADL
33%
Poorly correlated
-0.44%
MRNA - CADL
32%
Poorly correlated
-0.34%
RNAC - CADL
32%
Poorly correlated
+1.88%
More